Carbidopa | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Carbidopa
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2026-04-20

PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

Contact Supplier

Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

Contact Supplier

pharmacompass-2-m-2026-04-20

Carbidopa

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

46 API Suppliers, 22 USDMF, 17 CEP/COS, 7 JDMF, 3 EU WC, 8 KDMF, 15 NDC API, 18 Listed Suppliers

46 API Suppliers
22 USDMF
17 CEP/COS
7 JDMF
3 EU WC
8 KDMF
15 NDC API
18 Listed Suppliers

DEVELOPMENTS

57 Drugs in Development

57 Drugs in Development

FINISHED DOSAGE FORMULATIONS

790 FDF Dossiers, 162 FDA Orange Book, 481 Europe, 26 Canada, 72 Australia, 12 South Africa, 37 Listed Dossiers

790 FDF Dossiers
162 FDA Orange Book
481 Europe
26 Canada
72 Australia
12 South Africa
37 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET;ORAL - 25MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET;ORAL - 25MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 4 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 3 Kirsch Pharma, 1 Panvo Organics, 2 Cerata Pharmaceuticals LLP, 2 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 1 Finar, 12 Gangwal Chemicals, 2 Gloria Interchem, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 22 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 45 Disintegrants & Superdisintegrants, 37 Direct Compression, 35 Solubilizers, 34 Granulation, 33 Controlled & Modified Release, 32 Thickeners and Stabilizers, 26 Taste Masking, 23 Chewable & Orodispersible Aids, 23 Parenteral, 22 Film Formers & Plasticizers, 22 Lubricants & Glidants, 16 Co-Processed Excipients, 15 Topical, 9 API Stability Enhancers, 8 Emulsifying Agents, 6 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

79 Fillers, Diluents & Binders
57 Coating Systems & Additives
45 Disintegrants & Superdisintegrants
37 Direct Compression
35 Solubilizers
34 Granulation
33 Controlled & Modified Release
32 Thickeners and Stabilizers
26 Taste Masking
23 Chewable & Orodispersible Aids
23 Parenteral
22 Film Formers & Plasticizers
22 Lubricants & Glidants
16 Co-Processed Excipients
15 Topical
9 API Stability Enhancers
8 Emulsifying Agents
6 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 81 News #PharmaBuzz

3 Data Compilation #PharmaFlow
81 News #PharmaBuzz

GLOBAL SALES INFORMATION

44 US Medicaid Prescriptions, 69 Regulatory FDF Prices, 16 Annual Reports

44 US Medicaid Prescriptions
69 Regulatory FDF Prices
16 Annual Reports

MARKET PLACE

14 APIs, 9 FDF Dossiers

14 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

309 US Patents, 4 US Exclusivities, 9 Health Canada Patents

309 US Patents
4 US Exclusivities
9 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 9 Others

3 EDQM
1 USP
1 JP
9 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

3 All

01 1C0460000

02 1Y0001713

03 1Y0001716

filter CAS Number Reset all filters

3 All

01 238821-49-7

02 1N/A

filter Reference Standard Reset all filters

3 All

01 1Carbidopa

02 1Carbidopa for system suitability

03 1Carbidopa impurity mixture

Product Main Page

01

EDQM, Council of Europe

Carbidopa impurity mixture

PCC

Not Confirmed

01

EDQM, Council of Europe

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Carbidopa impurity mixture

CAS Number : N/A

Quantity Per Vial : 0.008 mg

Sale Unit : 1

Order Code : Y0001716

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Carbidopa for system suitability

PCC

Not Confirmed

02

EDQM, Council of Europe

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Carbidopa for system suitability

CAS Number : 38821-49-7

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001713

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Carbidopa

PCC

Not Confirmed

03

EDQM, Council of Europe

PCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CAS Number : 38821-49-7

Quantity Per Vial : 50 mg

Sale Unit : 1

Order Code : C0460000

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.